18 reports

The Future: What Next for Pain Relief?

  • Analgesic
  • OTC
  • Pain Relief
  • World
  • Demand

And there is no prophylactic drug that negates the need for pain relief. "

  • Pain Relief
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.

MAR ##, 2017: NEUROMETRIX GAINING INCREASED MEDIA COVERAGE OF QUELL WEARABLE PAIN RELIEF TECHNOLOGY IN 2017 NeuroMetrix, Inc. reported increased media attention in 2017 on the company' s Quell® Wearable Pain Relief Technology™.

  • Pain Relief
  • United States
  • Company Financials
  • Product Initiative
  • NeuroMetrix, Inc.

Unlike other medical devices providing local pain relief, the AVACEN ##' s unique mechanism of action offers widespread pain relief.

  • Clinical Trial
  • Drug Discovery And Development
  • Pain Relief
  • United States
  • GlobalData's company

Weifa is a provider of consumer health pain relief products and supplier of API for diabetes medicine and opiates for use in pain relief and cough medicine.

  • Pain Relief
  • Norway
  • Company Financials
  • M&A
  • Weifa

Sustained pain relief.

  • Clinical Trial
  • Hormone
  • Pain Relief
  • Pharmaceutical
  • World

Fast absorption is believed to correlate with rapid pain relief for migraine patients.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Zosano Pharma Corporation

The primary efficacy endpoint of the trial is pain relief as reported on a visual analog scale (VAS) in a subject diary, assessed through ## hours from initial dose.

  • Pain Relief
  • China
  • United States
  • Company
  • Capnia, Inc.

Both the ## mg and ## mg doses of lasmiditan were also more efficacious than placebo on headache pain relief at the two-hour time point (p ##. ##), as a rescue medication on headache pain freedom at the two-hour time point (p ##. ## and p ##. ##), in reducing migraine relat

  • Healthcare
  • Pain Relief
  • Pharmaceutical
  • United States
  • CoLucid Pharmaceuticals, Inc.

Reddy' s Laboratories Limited under Fed Conditions GDCT## NCT##, ## Women' s Health Osteoarthritis, Pain, Primary Dysmenorrhea, Rheumatoid Arthritis Completed Phase I Interventional ibuprofen Dr.

  • Arthritis
  • Clinical Trial
  • Hormone
  • Pain Relief
  • Bayer AG

Pain, Cognitive Impairment, Fatigue Ongoing, recruiting Phase III Interventional prednisone DR Minneapolis VA Medical Center United States Department of Defense ## Jul 2015 ## Jan 2020 ## ## ## Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily ## Group C Member ## or NR##C##) Agonist Glu

  • Clinical Trial
  • Pain Relief
  • World
  • Product Initiative
  • Merck & Co., Inc.

Pain Completed Phase II Interventional lidocaine; sodium bicarbonate; vasopressin University of California San Diego ## Dec 2007 ## Feb 2008 Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Collaborator(s) Ac

  • Hormone
  • Maternal Health
  • Pain Relief
  • Therapy
  • World

Ocular Pain Global Clinical Trials Review, H##, 2016 Reference Code: GDHC##CTIDB Publication Date: JUL 2016 LIST OF TABLES Ocular Pain Global Clinical Trials Review, H##, 2016 outlines clinical trials in Ocular Pain.

  • Drug Discovery And Development
  • Healthcare
  • Pain Relief
  • World
  • Product Initiative

The analgesic efficacy of treatment with metamizol versus placebo was statistically proven at a predefined significance level (##. ##; one-sided) across the defined primary and secondary end points like maximum pain intensity difference (MAXPID), number of subjects with at least a ##%

  • Pain Relief
  • World
  • Market Size
  • Product Initiative
  • Tonix Pharmaceuticals Holding Corp.

Pain, Back Pain, Dental Pain, Gouty Arthritis (Gout), Menstrual Cramps, Myalgia, Nasopharyngitis (Common Cold), Osteoarthritis Pain, Primary Dysmenorrhea, Rheumatoid Arthritis Pain, Tendon and Ligament Pain, Tension -Type Headache Completed Phase

  • Clinical Trial
  • Hormone
  • Pain Relief
  • World
  • Bayer AG

Pain GDCT## SLCTR/ 2013/ ##, Women' s Health Primary Dysmenorrhea Withdrawn Phase II Interventional mefenamic acid; nifedipine University of Sri Jayewardenepura ## Jul 2013 ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therap

  • Clinical Trial
  • OTC
  • Pain Relief
  • World
  • Product Initiative

Pain, Back Pain, Dental Pain, Dysmenorrhea, Infectious Fever, Migraine, Mild Pain, Moderate Pain, Myalgia, Nasopharyngitis (Common Cold), Neuralgia, Osteoarthritis Pain, Pain, Primary Dysmenorrhea, Rheumatoid Arthritis Pain, Ten

  • Neurology
  • OTC
  • Pain Relief
  • Pharmaceutical
  • GlaxoSmithKline plc

In a proof-of-concept clinical trial evaluating patients with frequent episodic migraine, ALD## demonstrated significant prevention of migraines, including complete migraine relief (##% suppression of migraine occurrence) in ##% to ##% of patients in any given month.

  • Drug Discovery And Development
  • Pain Relief
  • World
  • Product Initiative
  • Merck & Co., Inc.